DUDLEY ROBERT MICHAEL (Chief Executive Officer) purchased 2.3% of their position (20K shares) of TRANSCODE THERAPEUTICS, INC. on the open market
Open‑market purchase worth $23.0K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 9/16/2022ACC: 0001104659-22-100931
DirectorOfficer10% Owner· Chief Executive Officer
Since Jul 2021
+20K
Net shares
Net buyer
$23.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
20K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+20K
Price / share
$1.15
Trade value
$23K
% of position
2.3%
9/14/2022
873.11K→893.11K
Total
Net shares
+20K
Net value
$23K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/14/2022 | P · Purchase | +20K | $1.15 | $23K | 2.3% | 873.11K | 893.11K |
| Total | +20K | $23K | ||||||
Derivative Transactions0
No derivative transactions reported